← Back to Search

Genetic Education for Prostate Cancer

N/A

Recruiting

Led By Ewan K Cobran, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Localized prostate cancer (stage 1 and 2)

Age 40 and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after the intervention

Awards & highlights

Study Summary

This trial is investigating how well patients and their caregivers understand and communicate prognostic genetic technology surrounding localized prostate cancer.

Who is the study for?

This study is for English-speaking African American and rural White men aged 40 or older who have early-stage (stage 1 or 2) prostate cancer. Participants must be willing to provide informed consent and participate in the study. Men with advanced prostate cancer, plans to move soon, or severe mental illness like dementia cannot join.Check my eligibility

What is being tested?

The trial is focused on understanding how these men perceive genetic technology that helps predict the outcome of localized prostate cancer. It involves participating in focus group discussions to gather insights into their decision-making processes regarding treatment planning.See study design

What are the potential side effects?

Since this trial involves focus group discussions rather than medical treatments, there are no direct physical side effects associated with participation. However, discussing personal health issues can sometimes lead to emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My prostate cancer is in the early stages (1 or 2).

Select...

I am 40 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Estimate Genetic Literacy

Focus Group Discussion

Prostate Cancer Genetic Understanding

Secondary outcome measures

Demographic Characteristics

Prostate

Trial Design

2Treatment groups

Experimental Treatment

Group I: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video.Experimental Treatment1 Intervention

Focus group discussions about the PCGLA educational video post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.

Group II: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video plus Communication Coaching.Experimental Treatment1 Intervention

Focus group discussions about the PCGLA educational plus nurse-navigated, tailored, prostate cancer education and communication coaching post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus. post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,212 Previous Clinical Trials

3,766,948 Total Patients Enrolled

33 Trials studying Prostate Cancer

8,298 Patients Enrolled for Prostate Cancer

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,925,764 Total Patients Enrolled

560 Trials studying Prostate Cancer

507,005 Patients Enrolled for Prostate Cancer

University of GeorgiaLead Sponsor

101 Previous Clinical Trials

34,658 Total Patients Enrolled

Media Library

Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. Clinical Trial Eligibility Overview. Trial Name: NCT04550845 — N/A

Prostate Cancer Research Study Groups: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video., Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video plus Communication Coaching.

Prostate Cancer Clinical Trial 2023: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. Highlights & Side Effects. Trial Name: NCT04550845 — N/A

Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. 2023 Treatment Timeline for Medical Study. Trial Name: NCT04550845 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research venture currently engaging participants?

"According to clinicaltrials.gov, this medical study is not currently enrolling patients. It was first posted on September 27th 2022 and the most recent update was July 15th 2022. Despite that, there are still 1322 other trials actively recruiting participants right now."

Answered by AI

Are there any age restrictions for joining this trial?

"For this research, participants must be within the age range of 40 and 95 years old."

Answered by AI

Who has the eligibility to partake in this research project?

"This research requires 260 men aged between 40 and 95 with a diagnosis of prostate cancer. To be eligible, participants must meet the following prerequisites: Age of at least forty years old, male sex, and they must consent to participate in this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Understanding of Genetics by Men at Risk for Prostate Cancer

Ewan Cobran, Ph.D. 2023. "Understanding of Genetics by Men at Risk for Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04550845.

All > Prostate Cancer Glendale